Price
Target price
€0.38
€0.38
13.020%
0.044
13.020%
€1.85
08.12.23 / Stuttgart Stock Exchange
WKN: A2PL3P / Symbol: ONCT / Name: Oncternal Therapeutics / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Oncternal Therapeutics Inc. Stock
Oncternal Therapeutics Inc. dominated the market today, gaining €0.044 (13.020%).
Currently there is a rather negative sentiment for Oncternal Therapeutics Inc. with 3 Buy predictions and 16 Sell predictions..
On the other hand, the target price of 1 € is above the current price of 0.38 € for Oncternal Therapeutics Inc., so the potential is actually 161.78%.
Our community identified positive and negative aspects for Oncternal Therapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Oncternal Therapeutics Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Oncternal Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) was upgraded by analysts at Brookline Capital Management from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Show more
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONCT provided by MarketBeat